现代辅助三维适形放疗治疗乳腺癌中的急性放射性皮炎——剂量分布与患者相关因素的影响
本研究纳入2012年3月至2017年5月间255例保乳术后接受切线三维适形放疗的乳腺癌患者,中位处方剂量50.4 Gy,92.2%患者接受10-16 Gy序贯加量。42.4%发生I级、55.7% II级、2% III级皮肤毒性,23.1%出现湿性脱屑;多因素分析仅皮肤V80%为独立危险因素。
要点
- 255例保乳术后切线3D-CRT患者中,I级皮肤毒性42.4%、II级55.7%、III级2%,湿性脱屑23.1%。
- 单因素分析中乳房大小、CTV V107%、皮肤V105%和皮肤V80%与皮肤毒性显著相关(p<0.05)。
- 多因素分析仅皮肤V80%被确认为独立危险因素。
核心结论
- 现代切线多野3D-CRT可实现均匀剂量分布,皮肤毒性与IMRT研究相似。
- 皮肤剂量分布(V80%)可能对皮肤毒性严重程度和湿性脱屑的发生有相关影响。
研究设计与样本
- 本研究纳入2012年3月至2017年5月间255例保乳术后接受切线三维适形放疗的乳腺癌患者。
- 中位处方剂量为50.4 Gy(范围50-50.4 Gy),92.2%的患者接受10-16 Gy序贯加量。
- 治疗结束时按CTCAE v.4.03评估皮肤毒性并记录湿性脱屑发生情况,分析皮肤(患者轮廓外5 mm条带)和CTV剂量分布与CTCAE评分及湿性脱屑的相关性。
主要发现
- 42.4%的患者发生I级、55.7%发生II级、2%发生III级皮肤毒性;59例(23.1%)观察到湿性脱屑。
- CTV和皮肤内剂量分布均匀,仅小区域接受107%处方剂量(CTV中中位0.7 cm3)和105%处方剂量(皮肤中中位0.5 cm3)。
- 单因素分析中乳房大小、CTV V107%、皮肤V105%和皮肤V80%与皮肤毒性发生率显著相关(p<0.05)。
- 多因素分析仅皮肤V80%被确认为独立危险因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study was performed to evaluate skin toxicity during modern three-dimensional conformal radiotherapy (3D-CRT) and to evaluate the importance of dose distribution and patient related factors. MATERIAL AND METHODS: This study comprises 255 patients with breast cancer treated with tangential three-dimensional conformal radiotherapy (3D-CRT) after breast conserving surgery between 03/2012 and 05/2017. The median prescribed dose was 50.4 Gy (range 50-50.4) and 92.2% of the patients received a sequential boost of 10-16 Gy. Adverse skin toxicities (according to CTCAE v. 4.03 and the occurrence of moist desquamations) were assessed at the end of treatment. The dose distribution in the skin (5 mm strip from the patient outline) and in the CTV was evaluated and correlated to the CTCAE scores and the occurrence of moist desquamation. RESULTS: 42.4% of the patients developed grade I, 55.7% grade II and 2% grade III skin toxicities. Moist desquamation was observed in 59 cases (23.1%). Dose distribution within the CTV and skin was homogenous with only small areas receiving 107% of the prescribed dose (median: 0.7 cm3) in the CTV and 105% (median 0.5 cm3) in the skin. On univariate analysis breast size as well as V107%(CTV), V105%(skin) and V80%(skin) correlated significantly (p < 0.05) with the incidence of skin toxicity. On multivariate analysis only V80%(skin) was confirmed as independent risk factor. CONCLUSION: Modern tangential multi-field 3D-CRT allows a homogeneous dose distribution with similar skin toxicity as compared to studies performing IMRT. Dose distribution within the skin (V80%) might have a relevant impact on the severity of skin toxicity and the occurrence of moist desquamation.
引用
- Borm KJ, Loos M, Oechsner M, et al. Acute radiodermatitis in modern adjuvant 3D conformal radiotherapy for breast cancer - the impact of dose distribution and patient related factors. Radiat Oncol. 2018. PMID: 30404664. doi:10.1186/s13014-018-1160-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。